Current Advances in the Development of SARS-CoV-2 Vaccines
A special issue of Vaccines (ISSN 2076-393X).
Deadline for manuscript submissions: closed (15 September 2021) | Viewed by 546
Special Issue Editors
Interests: Immunity to emerging viral pathogens
Special Issues, Collections and Topics in MDPI journals
Interests: the requirements for the generation and maintenance of resident memory CD8 T cells
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
The ongoing SARS-CoV-2 pandemic has highlighted the need for rapid development, testing, distribution, and analysis of additional coronavirus vaccines. We are publishing this special issue to address these and many additional remaining questions for this pandemic. The appearance of multiple novel variants that exhibit the capacity to cause enhanced spread, pathogenesis, and/or evade prior immunological protection, with the added contribution of a strong potential for the emergence of additional novel variants, make it clear that additional vaccination and therapeutic efforts will be needed to resolve this pandemic. This special issue calls for submissions for manuscripts regarding many aspects of vaccines for SARS-CoV-2, including but not limited to:
◦ Duration of immunity
◦ Correlates of immunity
◦ Mechanisms of immunity
◦ Vaccine efficacy against viral variants
◦ Animal model development for testing SARS-CoV-2 vaccines
◦ Novel vaccines
◦ Adjuvants to improve vaccination
◦ Improvements in manufacturing and distribution of vaccines
◦ Optimal timing, routes, or dosing of vaccinations
Keywords
- vaccines
- SARS-CoV-2
- coronavirus
- variant
- immunity
- duration
- magnitude
- viral genetics
- protection
